The massive EPS beat is non-recurring and tied to a retroactive contract amendment and regulatory fee cut. Traders should focus on the sustainability of the 25-30% prospective reduction in normalized contract services expenses and monitor Q3 revenue trends for signs of stabilization or further decline.
Price Chart
Executive Summary
Nutex Health reported Q2 2026 diluted EPS of $9.38, a 78% beat vs the $5.26 consensus, driven by a one-time $52.3M reduction in contract services expense from a retroactive HaloMD amendment and CMS fee cut. However, total revenue fell 13.6% YoY to $210.8M, reflecting the impact of prior-year IDR process improvements, creating a mixed picture of a non-recurring earnings windfall against a declining top line.
Key Financial Metrics
Key Facts
- Diluted EPS of $9.38 vs consensus $5.26 (78% beat)
- Total revenue $210.8M, down 13.6% YoY from $244.0M
- Net income attributable to Nutex Health of $65.8M vs a loss of $17.7M in Q2 2025
- Operating cash flow of $34.2M vs $27.3M in Q2 2025
- One-time $52.3M reduction in contract services expense from retroactive HaloMD amendment and CMS fee reduction
- Cash balance of $205.2M, long-term debt of $31.1M
Financial Impact
EPS beat of $4.12 per share (78%) driven by a one-time $52.3M expense reduction; revenue decline of $33.2M (13.6%) YoY
Risk Factors
- Revenue decline may persist as prior-year IDR benefits normalize
- One-time expense reduction is not repeatable; future quarters may see higher costs
- Uncertainty around the No Surprises Act litigation and IDR process
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302845502 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | Press Release | $191.25 | awaiting T+20 | — | $204.66 (+7.01%) |
Aug 13, 2026 10w ago | 8-K | $187.42 $217.02 | ▲ +15.79% | ▲ +17.78% | $204.66 (+9.20%) |
Aug 6, 2026 11w ago | Press Release | $162.07 $193.24 | ▲ +19.23% | ▲ +19.63% | $204.66 (+26.28%) |
Jul 21, 2026 14w ago | Press Release | $168.27 $187.66 | ▲ +11.52% | ▲ +8.96% | $204.66 (+21.63%) |
May 8, 2026 24w ago | Court Ruling | $132.88 $135.40 | ▼ −1.90% | ▼ −2.20% | $204.66 (−54.02%) |
Mar 13, 2026 32w ago | Insider Cluster | $88.80 $106.27 | ▲ +19.67% | ▲ +16.08% | $204.66 (+130.48%) |
Mar 5, 2026 33w ago | 8-K | $90.28 $100.65 | ▲ +11.49% | ▲ +13.53% | $204.66 (+126.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers